Clinical Neuroscience Solutions, LLC

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder	anxiety disorder, generalized anxiety disorder, psychiatric disorder	Recruiting	Phase 3	2026-09-22	NCT07759128
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older	Clostridoides Difficile Associated Disease	Recruiting	Phase 3	2026-09-09	NCT07282665
An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)	Bipolar and Related Disorders, bipolar I disorder, bipolar II disorder, bipolar disorder, mood disorder, psychiatric disorder	Enrolling by invitation	Phase 3	2026-09-02	NCT07217860
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)	Bipolar and Related Disorders, bipolar I disorder, bipolar II disorder, bipolar disorder, mood disorder, psychiatric disorder	Recruiting	Phase 3	2026-09-02	NCT07172516
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arthritic joint disease, arthropathy, musculoskeletal system disorder, nutritional disorder, obesity disorder, osteoarthritis, osteoarthritis, knee, overnutrition, rheumatic disorder	Recruiting	Phase 3	2026-08-17	NCT07509307

Clinical trials